Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830451 · ClinicalTrials.gov registry record
Metastatic Tumor Research and Outcomes Network
A clinical trial of Metastatic Spine Tumor, sponsored by AO Innovation Translation Center.
- Active
- Registry status
- 960
- Enrollment target
- 20
- Study locations
NCT02830451 is a study of Metastatic Spine Tumor that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 960 participants. The trial reports 20 study locations across 18 states.
The verdict
NCT02830451, a study of Metastatic Spine Tumor, is active but no longer recruiting, sponsored by AO Innovation Translation Center.
- ACTIVE NOT RECRUITING
- Registry status
- 960 participants
- Enrollment target
- 20
- Study locations
Study Summary
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Conditions Studied
Study Locations (20)
New York
- Memorial Sloan-Kettering Cancer Center - New York
- University of Rochester School of Medicine and Dentistry Department of Orthopaedic Surgery and Neurosurgery - Rochester
Ontario
- Toronto Western Hospital Department of Neurosurgery Division of Surgery - Toronto
- University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter - Toronto
California
- University of California The UCSF Spine Center Department of Neurological Surgery - San Francisco
Illinois
- Rush University Medical Center University Neurosurgery - Chicago
Maryland
- Johns Hopkins University Department of Neurosurgery / Spine Division - Baltimore
Massachusetts
- Harvard Medical School Department of Neurosurgery - Boston
Minnesota
- Mayo Clinic Department of Neurosurgery - Rochester
Pennsylvania
- Penn Presbyterian Medical Center Department of Neurosurgery - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2026-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02830451
The ClinicalTrials.gov registry entry for NCT02830451 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Spine Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT02830451 reports 20 study locations spanning 18 distinct geographic areas - top geographies include New York, Ontario, California.
Frequently Asked Questions
What is clinical trial NCT02830451 about?
NCT02830451 is a clinical study titled "Metastatic Tumor Research and Outcomes Network". The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
What is the current status of trial NCT02830451?
This trial is currently active not recruiting. The enrollment target is 960 participants. The study started on 2017-11-15. Estimated completion is 2026-08-15.
What conditions does trial NCT02830451 study?
This clinical trial studies the following conditions: Metastatic Spine Tumor.
Who is sponsoring clinical trial NCT02830451?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02830451 being conducted?
This trial has 20 study locations across California, Illinois, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.